Cleared Traditional

K133754 - INTEGRA CAMINO FLEX VENTRICULAR INTRACRANIAL PRESSURE MONITORING KIT WITH FLEX ADAPTER

K133754 is an FDA 510(k) clearance for INTEGRA CAMINO FLEX VENTRICULAR INTRACR..., manufactured by Integra LifeSciences Corporation. The device is a Class 2 Neurology device with product code GWM cleared through the Traditional 510(k) pathway after a 87-day FDA review.

K133754 · Integra LifeSciences Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
87d
Days
Class 2
Risk

K133754 is an FDA 510(k) clearance for the INTEGRA CAMINO FLEX VENTRICULAR INTRACRANIAL PRESSURE MONITORING KIT WITH FLE.... Classified as Device, Monitoring, Intracranial Pressure (product code GWM), Class II - Special Controls.

Submitted by Integra LifeSciences Corporation (Plainsboro, US). The FDA issued a Cleared decision on March 6, 2014 after a review of 87 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1620 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Integra LifeSciences Corporation devices

FDA 510(k) Submission Details - K133754

510(k) Number K133754 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 09, 2013
Decision Date March 06, 2014
Days to Decision 87 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
61d faster than avg
Panel avg: 148d · This submission: 87d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWM Device Classification - Class 2, Special Controls

Product Code GWM Device, Monitoring, Intracranial Pressure
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1620
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWM Device, Monitoring, Intracranial Pressure

All 67
Devices cleared under the same product code (GWM) and FDA review panel - the closest regulatory comparables to K133754.
Codman Microsensor Basic Kit, Codman Microsensor Plastic Skull Bolt Kit, Codman Microsensor Ventricular Catheter Kit with Tuohy-Borst Adapter,Codman Microsensor Metal Skull Bolt Kit, Codman Microsensor Ventricular Catheter Kit
K153347 · Codman & Shurtleff, Inc. · Aug 2016
DirectLink ICP Module, DirectLink ICP Extension Cable, Patient Monitor Interface Cables
K152670 · Medos International SARL · Jan 2016
QFLOW 500 TITANIUM BOLT, QUAD LUMEN BOLT KIT
K141869 · Hemedex Incorporated · Oct 2014
RAUMEDIC-PTO-MONITORING-SYSTEM
K130529 · Raumedic AG · Oct 2013
INTEGRA LICOX PTO2 MONITOR
K131184 · Integra Lifesciences Corp. · Aug 2013
INTEGRA CAMINO ICP MONITOR
K121573 · Intrgra Lifesciences Corporation · Sep 2012